Anthos CEO On When Big Promo Efforts Are Needed, Telehealth's Acute Care Promise
Pandemic Catalyses Shifting Practices
Anthos Therapeutics’ CEO and ex-head of global commercial operations at Novartis Pharma, John Glasspool, tells Scrip there’s no "automatic premise" that the large promotional launch model is broken. He also outlines how teleconsultation is taking medicine back to its roots and "where it can be" as well, with patients less likely to get white coat syndrome.
